Insights from 2023 ESMO Annual Meeting
Avatar

ESMO 2023 Insights: "Brain Metastases & Survival Evaluation in the SECOMBIT Trial for Metastatic Melanoma"

By Insights from 2023 ESMO Annual Meeting FEATURING Paolo A. Ascierto
By Insights from 2023 ESMO Annual Meeting FEATURING Paolo A. Ascierto
128 views
November 24, 2023
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
16:02
Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

cfDNA for Liquid Biopsy for Patients With Glioblastoma

Feat. S. Bagley
10:01
AAD 2024 Insights

AAD 2024 Insights: The Latest Advances in the Treatment of Melanoma

Feat. V. Sondak
12:46
Stanford Medicine

FDA Approval of Lifileucel for Unresectable or Metastatic Melanoma: …

Feat. A. Betof Warner
13:23
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "A Pooled Analysis of T-DXd for HER2+ mBC Wi…

Feat. S. Hurvitz
17:33
Henry Friedman

Overview and Updates in Brain Tumors

23:09
Total Health

Key Updates in Skin Melanoma

Feat. R. Seedor
17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
06:39
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Final Analysis of Distant Metastasis-Free…

Feat. J. Luke
24:14
Masterclasses in Dermatology

Advances in the Treatment of Melanoma

Feat. D. Fisher
17:39
Melanoma Bridge 2023

Major Emerging Paradigm Shifts That Will Change Melanoma Management …

Feat. A. Eggermont
08:38
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "A Phase 3 Trial Comparing Fianlimab + Cem…

Feat. T. Panella
19:52
OncoAlert

Melanoma Updates: Adjuvant Therapy, Advanced Disease, Uveal Melanoma…

Feat. A. Betof Warner
10:39
University of Colorado Department of Medicine

Cardio-Oncology: Definitions and Scope

Feat. L. Kondapalli
05:37
Melanoma Bridge 2023

COLUMBUS 7-Year Update: Encorafenib + Binimetinib vs. Vemurafenib or…

Feat. R. Dummer
12:26
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024

2024 Neuro-Oncology Update: NSCLC and Brain Mets

Feat. T. McGranahan
08:46
Sapna Patel

Neoadjuvant Immunotherapy in the Treatment of Melanoma: What Do We K…

14:00
Melanoma Bridge 2023

Is SLN Biopsy No Longer Necessary for Patients With High-Risk Primar…

Feat. J. Luke
52:19
Winship Melanoma and Cutaneous Oncology Symposium

2024 Updates on Neoadjuvant Therapy for Resectable Melanoma

Feat. S. Patel
20:09
Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

Medical and Symptom Management of Patients With Brain Tumors

Feat. A. Pruitt
08:21
Total Health

Systemic Therapy for HER2+ CNS Disease: Management of Breast Cancer …

Feat. C. Santa-Maria